Neumonía por Pneumocystis jiroveci post inicio de tratamiento con infliximab en paciente con enfermedad de Crohn
Pneumocystis jiroveci pneumonia following infliximab therapy in patient with Crohn's disease
Rev. chil. infectol; 34 (5), 2017
Publication year: 2017
There are no evidence-based guidelines about prophylaxis against Pneumocystis jiroveci pneumonia in inflammatory bowel disease. We report a case of P. jiroveci pneumonia in patient with Crohn's disease receiving infliximab and methotrexate. This case emphasizes the importance of considering the possibility of this infection in inflammatory bowel disease patients treated on biological therapy.
Enfermedad de Crohn/tratamiento farmacológico, Fármacos Gastrointestinales/efectos adversos, Infliximab/efectos adversos, Neumonía por Pneumocystis/inducido químicamente, Inmunosupresores/efectos adversos, Neumonía por Pneumocystis/diagnóstico por imagen, Radiografía, Factores de Riesgo, Tomografía Computarizada por Rayos X